BioInfra Life Science Inc. (XKON:266470)

South Korea flag South Korea · Delayed Price · Currency is KRW
110.00
-3.00 (-2.65%)
At close: Apr 17, 2026
Market Cap2.38B -72.5%
Revenue (ttm)1.78B +27.5%
Net Income-3.59B
EPS-266.28
Shares Out21.67M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,103
Average Volume13,802
Open102.00
Previous Close113.00
Day's Range102.00 - 111.00
52-Week Range81.00 - 425.00
Beta0.18
RSI37.06
Earnings Daten/a

About BioInfra Life Science

BioInfra Life Science Inc., a healthcare company, develops cancer gene treatments and technologies that monitor the possibility of metastasis and recurrence in blood for cancer patients in South Korea. It provides cancer screening test technology service, cancer biomarker research, in-vitro diagnostics medical devices, and targeted drug delivery systems for cancer treatment. The company was founded in 2001 and is headquartered in Seoul, South Korea. [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2001
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 266470
Full Company Profile